Marks Gilbert Lynn

AN2 Therapeutics, Inc. · Director

Marks Gilbert Lynn is listed in public filings as director. This Marks Gilbert Lynn insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include AN2 Therapeutics, Inc. (ANTX). Investors use Marks Gilbert Lynn's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
AN2 Therapeutics, Inc.ANTX--79.1k sharesGrant / ExerciseApr 10, 2026Disclosure amount unavailable3.8k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
AN2 Therapeutics, Inc.ANTX$010.4k sharesOtherMar 19, 2026$179.1K10.4k shares$17.28--
AN2 Therapeutics, Inc.ANTX$023.7k sharesOtherMar 19, 2026$140.3K23.7k shares$5.91--
AN2 Therapeutics, Inc.ANTX$93k23.7k sharesGrant / ExerciseMar 19, 2026$92.8K23.7k shares$3.91--
AN2 Therapeutics, Inc.ANTX$010.7k sharesOtherMar 19, 2026$70.3K10.7k shares$6.60--
AN2 Therapeutics, Inc.ANTX$42k10.7k sharesGrant / ExerciseMar 19, 2026$41.7K10.7k shares$3.91--
AN2 Therapeutics, Inc.ANTX$41k10.4k sharesGrant / ExerciseMar 19, 2026$40.5K10.4k shares$3.91--
AN2 Therapeutics, Inc.ANTX$21k20.4k sharesGrant / ExerciseFeb 20, 2026$21.2K20.4k shares$1.04--
AN2 Therapeutics, Inc.ANTX--75.3k sharesGrant / ExerciseJan 12, 2026Disclosure amount unavailable11.6k shares----
AN2 Therapeutics, Inc.ANTX--63.7k sharesGrant / ExerciseOct 10, 2025Disclosure amount unavailable10.4k shares----
AN2 Therapeutics, Inc.ANTX--53.4k sharesGrant / ExerciseJul 10, 2025Disclosure amount unavailable11.9k shares----
AN2 Therapeutics, Inc.ANTX$23k19.1k sharesGrant / ExerciseMay 22, 2025$22.7K19.1k shares$1.19--
AN2 Therapeutics, Inc.ANTX--41.5k sharesGrant / ExerciseApr 10, 2025Disclosure amount unavailable9.7k shares----
AN2 Therapeutics, Inc.ANTX--31.8k sharesGrant / ExerciseDec 19, 2024Disclosure amount unavailable9k shares----
AN2 Therapeutics, Inc.ANTX$129k64.5k sharesGrant / ExerciseJun 19, 2024$129.0K64.5k shares$2.00--